BridgeMD
New treatment option for Irritable Bowel Disease
Official title Pain in Pediatric Patients - Internet Interventions for Disorders of Gut-brain Interaction
ClinicalTrials.gov ID: NCT07319078
What this study is testing
- What it's testing
- Many children and adolescents often experience long-lasting stomach pain. In many cases, this is due to disorders of gut-brain interaction (DGBI), such as irritable bowel syndrome (IBS), functional abdominal pain, and functional dyspepsia.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 17
You may be able to join if
- Age 8-17 years
- Basic somatic work-up completed (CRP/ESR, TGA, complete blood count, fecal calprotectin)
- Confirmed DGBI diagnosis: IBS, functional abdominal pain, or functional dyspepsia (according to Rome IV criteria)
- Any constipation must be treated according to current clinical guidelines, with stable laxative dosing for at least one month prior to referral
- In cases of celiac disease, the participant must have followed a gluten-free diet for at least six months and TGA values must have normalized
You likely can't join if
- Other organic disease that better explains the gastrointestinal symptoms
- At referral assessment, psychiatric symptoms or psychosocial problems - such as severe bullying, high school absenteeism, or difficult family...
- Participants who have already completed gut-directed hypnotherapy or CBT
See the full eligibility criteria
- Age 8-17 years
- Basic somatic work-up completed (CRP/ESR, TGA, complete blood count, fecal calprotectin)
- Confirmed DGBI diagnosis: IBS, functional abdominal pain, or functional dyspepsia (according to Rome IV criteria)
- Any constipation must be treated according to current clinical guidelines, with stable laxative dosing for at least one month prior to referral
- In cases of celiac disease, the participant must have followed a gluten-free diet for at least six months and TGA values must have normalized
- For participants with a neuropsychiatric diagnosis treated with medication, at least two months must have passed since the last dose adjustment
- At least one parent and the child/adolescent must be fluent in Swedish and willing to participate in both the educational program and treatment (regardless of randomization outcome), complete homework assignments, and...
- Other organic disease that better explains the gastrointestinal symptoms
- At referral assessment, psychiatric symptoms or psychosocial problems - such as severe bullying, high school absenteeism, or difficult family circumstances - are judged to be more prominent than the gastrointestinal...
- Participants who have already completed gut-directed hypnotherapy or CBT
The study team makes the final eligibility decision.
Where it's taking place
- Stockholm, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Stockholm, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.